Graduating renal fellow survey
Time is running out for graduating fellows to complete the quick 9 question survey to find out what kind of jobs are out there. It only takes a minute! RFN will take the poll down in a week…
Nephrology board prep
The results are in. Looks like the best way to study for the nephrology board exam, scheduled to be given on November 4th, 2010, is the ASN Board Review Course. I personally did not attend this course last…
Chocolate for cardiovascular health?
As this is restaurant week in Durham, NC, I thought it would be fitting to blog about the health benefits of food, in particular the delicacy that is ‘dark chocolate’. This is not a new idea in the…
Find RFN on Facebook
The Renal Fellow Network has finally joined Facebook. Find us on Facebook and get daily updates on blog posts from the site plus relevant kidney related news from around the world.
RFN now an ISN web favorite
The International Society of Nephrology (ISN) has designated the Renal Fellow Network as an ISN web favorite. The contributors to the RFN are proud of this designation and plan on continuing this wonderful resource for nephrology fellows (and…
The final blow for high dose B-vitamins?
Efforts aimed at lowering homocysteine levels in order to prevent the progression of CKD and cardiovascular disease takes another major hit in the April 28 issue of JAMA. High dose B-vitamin therapy has been shown to lower the…
Surviving lactic acidosis; lessons from turtles
Lactic acidosis is frequently seen in the hospital setting. Diverse etiologies account for the accumulation of lactic acid as reviewed by Nathan last year. The main impetus for the production of lactate is having a hypoxic state either…
The great salt war; population-wide salt reduction
Population-wide salt reduction is gaining increased media and political attention over the last few years. The most notable example is the National Salt Reduction Initiative (NSRI) spearheaded by New York City Mayor Michael Bloomberg. This initiative was unveiled…
How low can we go for blood pressure control?
The much awaited results from the ACCORD-BP trial were recently presented at the ACC scientific session in Atlanta and published online in the NEJM on March 14th. The Action to Control Cardiovascular Risk in Diabetes (ACCORD) was a…
A trap for angiotensin type 1 receptors
The renin-angiotensin system is powerful regulator of blood pressure homeostasis. An article published in the March 24 issue of JASN highlights an emerging area of research into the modulation of AT1 receptors on different tissues. The majority of…